Research for acquired immunity according to COVID-19 vaccination

Conditions

COVID-19

Uwamino Y, Yokoyama T, Sato Y, Shibata A, Kurafuji T, Tanabe A, Noguchi M, Arai T, Ohno A, Yokota H, Namkoong H, Nishimura T, Kosaki K, Hasegawa N, Wakui M, Murata M, Matsushita H.

2023-01-316 citations

10.1016/j.vaccine.2023.01.049

Dynamics of antibody titers and cellular immunity among Japanese healthcare workers during the 6 months after receiving two doses of BNT162b2 mRNA vaccine.

Uwamino Y, Kurafuji T, Takato K, Sakai A, Tanabe A, Noguchi M, Yatabe Y, Arai T, Ohno A, Tomita Y, Shibata A, Yokota H, Yamasawa W, Namkoong H, Sato Y, Hasegawa N, Wakui M, Murata M, Keio Donner Project Team.

2022-06-1720 citations

10.1016/j.vaccine.2022.06.016

The effect of the E484K mutation of SARS-CoV-2 on the neutralizing activity of antibodies from BNT162b2 vaccinated individuals.

Uwamino Y, Yokoyama T, Shimura T, Nishimura T, Sato Y, Wakui M, Kosaki K, Hasegawa N, Murata M.

2022-02-148 citations

10.1016/j.vaccine.2022.02.047

Young age, female sex, and presence of systemic adverse reactions are associated with high post-vaccination antibody titer after two doses of BNT162b2 mRNA SARS-CoV-2 vaccination: An observational study of 646 Japanese healthcare workers and university staff.

Uwamino Y, Kurafuji T, Sato Y, Tomita Y, Shibata A, Tanabe A, Yatabe Y, Noguchi M, Arai T, Ohno A, Yokota H, Yamasawa W, Uno S, Nishimura T, Hasegawa N, Saya H, Wakui M, Murata M, Keio Donner Project Team.

2022-01-0742 citations

10.1016/j.vaccine.2022.01.002

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Faculty stuffs and hospital stuffs of Keio University Shinanomachi campus Vaccinated or planned to be vaccinated for COVID-19 vaccine Capable for informed consent and blood collection

Exclusion criteria

Exclusion criteria: Minors Contraindicated for vaccination

Design outcomes

Primary

Measure	Time frame
acquisition rate of cellular and humoral immunity for SARS-CoV-2	—

Countries

Japan

Contacts

Public ContactYoshifumi Uwamino

Keio University School of Medicine Department of Laboratory Medicine

uwamino@keio.jp03-3353-1211

Outcome results